The Committee adopted by majority a positive opinion for an initial marketing authorisation application for Imrestor (pegbovigrastim)  from Eli Lilly and Company Limited  a veterinary medicinal product for use in the herd management programme as an aid to reduce the risk of clinical mastitis in periparturient dairy cows and heifers during the 30 days following calving